Article

How Age Alters the Appearance of Scleroderma

A study of more than 1,000 patients with systemic sclerosis over 5 years has revealed how symptoms and outcomes vary with age at onset.

Alba MA, Velasco C, Simeón CP, et al. Early- versus Late-Onset Systemic Sclerosis: Differences in Clinical Presentation and Outcome in 1037 PatientsMedicine, (2014). 93:73–81. doi: 10.1097/MD.0000000000000018

In systemic sclerosis, age at disease onset is associated with differences in clinical presentation and outcome.

The Spanish Scleroderma Study Group followed 1,037 patients for a mean followup of five years. The  investigators compared the initial and cumulative manifestations, immunologic features, and death rates for three age groups at onset: early standard, and late.

Standardized mortality was higher in younger patients. The article contains far more detail about symptoms and outcomes than those included in the chart below.

[[{"type":"media","view_mode":"media_crop","fid":"23311","attributes":{"alt":"scleroderma","class":"media-image","id":"media_crop_2764730322386","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"1817","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":" ","typeof":"foaf:Image"}}]]

 

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.